SAN FRANCISCO, CA, Prellis Biologics today announced that Khosla Ventures has led an $8.7 Series A investment in the company.
About The Author
UK’s Farewill raises $25M for its new approach online will writing, funerals and other death services
July 8, 2020
February 12, 2019
January 21, 2023